RVTY – revvity, inc. (US:NASDAQ)

News

Revvity to Present at J.P. Morgan Healthcare Conference
Revvity, Inc. (NYSE: RVTY) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $138.00 price target on the stock.
Revvity, Inc. (NYSE: RVTY) had its price target lowered by analysts at Barclays PLC from $140.00 to $135.00. They now have an "overweight" rating on the stock.
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com